|
IT1062206B
(it)
|
1974-02-01 |
1983-09-20 |
Rotta Research Lab S P A A S |
Derivati della tirosina attivi sulla muscolatura liscia
|
|
DE2423536A1
(de)
|
1974-05-15 |
1975-11-27 |
Bayer Ag |
3-amino-phenylessigsaeure-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
|
|
SK94393A3
(en)
*
|
1992-09-11 |
1994-08-10 |
Thomae Gmbh Dr K |
Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
AU691201B2
(en)
*
|
1993-11-01 |
1998-05-14 |
Japat Ltd. |
Endothelin receptor antagonists
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
EP0996459B1
(en)
|
1997-01-07 |
2005-09-21 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the reduction of food intake
|
|
HUP0003921A3
(en)
|
1997-07-31 |
2001-03-28 |
Wyeth Corp |
Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use
|
|
AR016133A1
(es)
*
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
CN1276785A
(zh)
*
|
1997-08-22 |
2000-12-13 |
霍夫曼-拉罗奇有限公司 |
N－烷酰基苯丙氨酸衍生物
|
|
BR9811730B1
(pt)
*
|
1997-08-22 |
2014-04-08 |
Hoffmann La Roche |
Derivados de n-aroilfenilalanina, uso dos mesmos, medicamentos contendo os mesmos.
|
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
JP4245682B2
(ja)
*
|
1997-12-25 |
2009-03-25 |
協和発酵キリン株式会社 |
キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤
|
|
US6197794B1
(en)
*
|
1998-01-08 |
2001-03-06 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
MY153569A
(en)
*
|
1998-01-20 |
2015-02-27 |
Mitsubishi Tanabe Pharma Corp |
Inhibitors of ?4 mediated cell adhesion
|
|
JP2002538081A
(ja)
|
1998-12-07 |
2002-11-12 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
Ｇｌｐ−１の類似体
|
|
NZ512663A
(en)
|
1999-01-14 |
2004-05-28 |
Amylin Pharmaceuticals Inc |
Novel exendin agonist formulations and methods of administration thereof
|
|
AU3487500A
(en)
*
|
1999-02-08 |
2000-08-25 |
Lion Bioscience Ag |
Thiazole derivatives and combinatorial libraries thereof
|
|
JP3795305B2
(ja)
*
|
1999-07-19 |
2006-07-12 |
田辺製薬株式会社 |
医薬組成物
|
|
TWI302149B
(en)
|
1999-09-22 |
2008-10-21 |
Bristol Myers Squibb Co |
Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
|
|
EP1233013B1
(en)
*
|
1999-11-18 |
2007-02-28 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivatives
|
|
RU2270193C2
(ru)
*
|
1999-12-06 |
2006-02-20 |
Ф.Хоффманн-Ля Рош Аг |
4-пиридинил-n-ацил-l-фенилаланины
|
|
RU2281283C2
(ru)
|
2000-03-07 |
2006-08-10 |
Санофи-Авентис Дойчланд Гмбх |
Замещенные 3-фенил-5-алкокси-1,3,4-оксадиазол-2-оны и их применение для ингибирования гормоночувствительной липазы
|
|
US6960597B2
(en)
*
|
2000-06-30 |
2005-11-01 |
Orth-Mcneil Pharmaceutical, Inc. |
Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
|
|
SK287781B6
(sk)
*
|
2000-08-18 |
2011-09-05 |
Ajinomoto Co., Inc. |
Fenylalanínové deriváty, farmaceutický prípravok s ich obsahom a ich použitie
|
|
JP4895067B2
(ja)
*
|
2000-09-29 |
2012-03-14 |
味の素株式会社 |
新規フェニルアラニン誘導体
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
EP1454898A4
(en)
*
|
2001-12-13 |
2006-12-13 |
Ajinomoto Kk |
NEW PHENYL ALANIDE DERIVATIVES
|
|
AU2003211560A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivative
|
|
WO2003089410A1
(en)
*
|
2002-04-19 |
2003-10-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Phenylalanine derivative
|
|
US20070276034A1
(en)
|
2002-05-31 |
2007-11-29 |
Luke Esposito |
Compounds, compositions and methods for the treatment of synucleinopathies
|
|
PT1537116E
(pt)
|
2002-09-04 |
2010-09-03 |
Schering Corp |
Pirazolopirimidinas adequadas para o tratamento de doenças cancerosas
|
|
WO2004022561A1
(en)
|
2002-09-04 |
2004-03-18 |
Schering Corporation |
Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
|
|
US20040152750A1
(en)
|
2002-12-20 |
2004-08-05 |
Kodra Janos Tibor |
Novel glucagon antagonists
|
|
EP1595870B1
(en)
*
|
2003-02-20 |
2015-09-23 |
Ajinomoto Co., Inc. |
Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
|
|
EA008798B1
(ru)
|
2003-06-13 |
2007-08-31 |
Лабораториос С.А.Л.В.А.Т., С.А. |
НОВЫЕ БЕНЗАМИДЫ В КАЧЕСТВЕ PPARγ МОДУЛЯТОРОВ
|
|
KR101194176B1
(ko)
*
|
2003-12-22 |
2012-10-24 |
아지노모토 가부시키가이샤 |
신규한 페닐알라닌 유도체
|
|
KR20070004676A
(ko)
*
|
2004-02-10 |
2007-01-09 |
얀센 파마슈티카 엔.브이. |
알파４ 인테그린의 길항제로서의 피리다지논
|
|
JP2005263787A
(ja)
*
|
2004-02-17 |
2005-09-29 |
Ishihara Sangyo Kaisha Ltd |
アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
|
|
US7618981B2
(en)
*
|
2004-05-06 |
2009-11-17 |
Cytokinetics, Inc. |
Imidazopyridinyl-benzamide anti-cancer agents
|
|
WO2006117743A1
(en)
|
2005-05-03 |
2006-11-09 |
Ranbaxy Laboratories Limited |
Substituted aromatic compounds as antidiabetic agents
|
|
WO2006127595A1
(en)
|
2005-05-23 |
2006-11-30 |
Arena Pharmaceuticals, Inc. |
5-aminopyrazole carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
WO2006137450A1
(ja)
*
|
2005-06-21 |
2006-12-28 |
Ajinomoto Co., Inc. |
フェニルアラニン誘導体の結晶、その製造方法及びその使用
|
|
JP2009516729A
(ja)
*
|
2005-11-23 |
2009-04-23 |
アストラゼネカ アクチボラグ |
Ｌ−フェニルアラニン誘導体
|
|
EP2049490A1
(en)
*
|
2006-06-09 |
2009-04-22 |
Astra Zeneca AB |
N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl]-l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors
|
|
EP1878730A1
(en)
|
2006-07-12 |
2008-01-16 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same
|
|
CN101589028B
(zh)
*
|
2006-11-22 |
2014-02-19 |
味之素株式会社 |
具有喹唑啉二酮骨架的苯丙氨酸衍生物的制备方法及制备中间体
|
|
WO2008064823A1
(en)
*
|
2006-11-27 |
2008-06-05 |
Ucb Pharma, S.A. |
Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
|
|
WO2008112939A2
(en)
|
2007-03-13 |
2008-09-18 |
Board Of Regents, The University Of Texas System |
Composition and method for making oligo-benzamide compounds
|
|
EP2155720B1
(en)
|
2007-06-08 |
2013-07-17 |
Advinus Therapeutics Private Limited |
Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
|
|
EP2205085A1
(en)
*
|
2007-09-25 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
2-aryl or heteroaryl indole derivatives
|
|
WO2011094890A1
(en)
*
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
EP2853529A1
(en)
*
|
2010-03-29 |
2015-04-01 |
Ajinomoto Co., Inc. |
Crystals of salts of phenylalanine derivatives
|
|
US8501982B2
(en)
|
2010-06-09 |
2013-08-06 |
Receptos, Inc. |
GLP-1 receptor stabilizers and modulators
|
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規ｇｌｐ−１受容体安定剤および調節剤
|
|
US8999975B2
(en)
*
|
2011-09-19 |
2015-04-07 |
Boehringer Ingelheim International Gmbh |
Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
|
|
AU2012352349B2
(en)
*
|
2011-12-12 |
2017-08-17 |
Receptos Llc |
Carboxylic acid derivatives comprising four cycles acting as GLP-1 receptor modulators for therapy of diseases such as diabetes
|
|
CN109867630A
(zh)
|
2013-06-11 |
2019-06-11 |
赛尔基因第二国际有限公司 |
新型glp-1受体调节剂
|
|
EP3172199B1
(en)
|
2014-07-25 |
2020-07-01 |
Celgene International II Sarl |
Pyrimidine derivatives as glp-1 receptor modulators
|